- Bortezomib breast cancer

50.52% | 515 votes

Purpose. The incidence of bone metastasis in advanced. The incidence of bone metastasis in advanced breast cancer exceeds 70%. Bortezomib (Bzb), a proteasome inhibitor used for the treatment of.

Categories: Breast expansion


By Kagami - 18:55
The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer. Thaler S(1), Thiede G(1).
By Daitilar - 23:29
Abstract. There is increasing interest in the proteasome inhibitor, bortezomib (PS), as a breast cancer therapeutic. However, early clinical studies of.
By Samushura - 19:11
In vivo efficacy of bortezomib was tested in nude mice with breast cancer xenografts. Immunohistochemical study was performed on tumor.
By Faer - 03:29
We performed a phase II study of bortezomib to evaluate its clinical effects in patients with metastatic breast cancer. Patients and methods: Twelve patients with.
By Malazuru - 20:26
Overall, the present results suggest that bortezomib and BAPTA‑AM combination therapy may be a novel therapeutic strategy for breast cancer.

Related Videos